Zydus gets US FDA nod to start Phase 2 clinical trials of Saroglitazar Magnesium
Healthcare major Zydus Cadila on Thursday announced having received US drug regulator US Food and Drug Administration (USFDA) approval for the group's plans to initiate a Phase-2 clinical trial of...23-02-2017